Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

NCT05529524 is registered in ClinicalTrials.gov with The Lymphoma Academic Research Organisation as lead sponsor.

NCT NCT05529524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05529524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
Lead sponsor
The Lymphoma Academic Research Organisation
Phase
Observational
Overall status
Completed
Start date
November 7, 2022
Completion date
January 22, 2024
Enrollment
6 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma